Ann: Quarterly Report and Appendix 4C, page-7

Don’t be emotional. Obviously, EXL is making a loss again in 3Q. And it’s annual revenue growth is less than main competitors: cw hemp 170% and cv sciences 200%, even with a bigger base. If you go back to the previous annual report, they said they will move to new facility by October, and now they say nothing about it. Everything I said are backed by evidence. I said disappointed, not saying it’s a bad business. It’s still a good one, just not as good as other market leaders. If you do not agree, show your evidence.